Recro Pharma (REPH) Short Interest Ratio & Short Volume → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free REPH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Recro Pharma Short Interest DataCurrent Short Volume669,900 sharesPrevious Short Volume743,600 sharesChange Vs. Previous Month-9.91%Dollar Volume Sold Short$1.11 millionShort Interest Ratio / Days to Cover4.0Last Record DateFebruary 28, 2022Outstanding Shares56,424,000 sharesFloat Size42,320,000 sharesShort Percent of Float1.58%Today's Trading Volume141,800 sharesAverage Trading Volume126,298 sharesToday's Volume Vs. Average112% Short Selling Recro Pharma ? Sign up to receive the latest short interest report for Recro Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatREPH Short Interest Over TimeREPH Days to Cover Over TimeREPH Percentage of Float Shorted Over Time Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Recro Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/2022669,900 shares $1.11 million -9.9%1.6%4 $1.66 2/15/2022743,600 shares $1.30 million -10.1%1.8%4.1 $1.75 1/31/2022827,100 shares $1.27 million -3.8%2.0%3.1 $1.54 1/15/2022859,600 shares $1.43 million -2.0%2.0%3.1 $1.66 12/31/2021876,900 shares $1.50 million +6.8%2.1%2.9 $1.71 12/15/2021820,800 shares $1.32 million -6.6%1.9%2.5 $1.61 Get the Latest News and Ratings for REPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Recro Pharma and its competitors with MarketBeat's FREE daily newsletter. 11/30/2021878,700 shares $1.38 million +6.7%2.1%2.7 $1.57 11/15/2021823,800 shares $1.40 million +22.5%1.9%2.5 $1.70 10/29/2021672,500 shares $1.31 million +4.3%1.6%2.2 $1.95 10/15/2021645,100 shares $1.19 million -4.6%1.5%2.2 $1.85 9/30/2021676,100 shares $1.39 million +22.6%1.6%2.1 $2.06 9/15/2021551,500 shares $1.20 million -5.5%1.3%1.4 $2.18 8/31/2021583,800 shares $1.42 million -13.3%1.4%1.3 $2.43 8/13/2021673,600 shares $1.68 million -1.0%1.6%1.4 $2.50 7/30/2021680,500 shares $1.24 million -24.6%1.6%1.3 $1.82 7/15/2021903,000 shares $1.65 million +2.2%2.1%1.7 $1.83 6/30/2021883,300 shares $2.04 million -36.9%2.1%1.7 $2.31 6/15/20211,400,000 shares $2.88 million +5.3%3.3%3 $2.06 5/28/20211,330,000 shares $3.05 million +7.3%3.3%3.5 $2.29 5/14/20211,240,000 shares $2.89 million -3.1%N/A2.7 $2.33 4/30/20211,280,000 shares $3.40 million -18.0%N/A2.7 $2.66 4/15/20211,560,000 shares $4.60 million +9.1%N/A3 $2.95 3/31/20211,430,000 shares $3.63 million -1.4%N/A2.2 $2.54 3/15/20211,450,000 shares $5.42 million +15.1%N/A2 $3.74 2/26/20211,260,000 shares $6.19 million -6.0%N/A1 $4.91 2/12/20211,340,000 shares $6.14 million -6.9%6.8%1.1 $4.58 1/29/20211,440,000 shares $4.45 million +47.9%7.3%1.3 $3.09 1/15/2021973,600 shares $2.88 million -0.2%5.0%0.9 $2.96 12/31/2020975,500 shares $2.85 million +1.0%4.9%1 $2.92 12/15/2020965,700 shares $3.31 million +13.4%4.9%1.1 $3.43 11/30/2020851,300 shares $2.13 million +3.9%4.3%3.2 $2.50 11/15/2020819,400 shares $1.54 million -10.3%4.1%2.9 $1.88 10/30/2020913,800 shares $1.54 million +40.2%4.6%3.1 $1.69 10/15/2020651,600 shares $1.41 million +13.3%3.3%2.1 $2.17 9/30/2020574,900 shares $1.21 million -10.1%2.9%1.8 $2.10 9/15/2020639,200 shares $1.35 million -15.0%3.2%1.9 $2.11 8/31/2020751,600 shares $2.07 million +5.3%3.8%2 $2.75 8/14/2020713,600 shares $2.17 million +7.5%3.6%1.8 $3.04 7/31/2020663,800 shares $2.71 million +1.2%3.3%1.1 $4.09 7/15/2020656,000 shares $2.72 million -31.9%3.3%1.2 $4.14Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… REPH Short Interest - Frequently Asked Questions What is Recro Pharma's current short interest? Short interest is the volume of Recro Pharma shares that have been sold short but have not yet been closed out or covered. As of February 28th, investors have sold 669,900 shares of REPH short. 1.58% of Recro Pharma's shares are currently sold short. Learn More on Recro Pharma's current short interest. What is a good short interest ratio for Recro Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. REPH shares currently have a short interest ratio of 4.0. Learn More on Recro Pharma's short interest ratio. What is a good short interest percentage for Recro Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.58% of Recro Pharma's floating shares are currently sold short. Is Recro Pharma's short interest increasing or decreasing? Recro Pharma saw a decrease in short interest in the month of February. As of February 28th, there was short interest totaling 669,900 shares, a decrease of 9.9% from the previous total of 743,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Recro Pharma's float size? Recro Pharma currently has issued a total of 56,424,000 shares. Some of Recro Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Recro Pharma currently has a public float of 42,320,000 shares. How does Recro Pharma's short interest compare to its competitors? 1.58% of Recro Pharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Recro Pharma: CervoMed Inc. (0.54%), Vistagen Therapeutics, Inc. (5.48%), InterCure Ltd. (0.39%), Societal CDMO, Inc. (0.34%), Seres Therapeutics, Inc. (12.18%), ProPhase Labs, Inc. (1.76%), Allakos Inc. (6.37%), Kinnate Biopharma Inc. (2.01%), Sagimet Biosciences Inc. (14.76%), IO Biotech, Inc. (0.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.96 billion), Palo Alto Networks, Inc. ($4.37 billion), Lucid Group, Inc. ($2.87 billion), Moderna, Inc. ($2.70 billion), Rivian Automotive, Inc. ($2.31 billion), Wayfair Inc. ($2.29 billion), Snap Inc. ($2.23 billion), Datadog, Inc. ($2.21 billion), Live Nation Entertainment, Inc. ($1.96 billion), and Zoom Video Communications, Inc. ($1.89 billion). View all of the most shorted stocks. What does it mean to sell short Recro Pharma stock? Short selling REPH is an investing strategy that aims to generate trading profit from Recro Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Recro Pharma? A short squeeze for Recro Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of REPH, which in turn drives the price of the stock up even further. How often is Recro Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REPH, twice per month. The most recent reporting period available is February, 28 2022. More Short Interest Resources from MarketBeat Related Companies: CRVO Short Squeeze VTGN Short Squeeze INCR Short Squeeze SCTL Short Squeeze MCRB Short Squeeze PRPH Short Squeeze ALLK Short Squeeze KNTE Short Squeeze SGMT Short Squeeze IOBT Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:REPH) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy